{"schema_version":"secwatch.filing_event.v1","accession":"0001683168-23-004371","form_type":"8-K","ticker":"CPMD","cik":"0001081938","company_name":"CANNAPHARMARX, INC.","filed_at":"2023-06-23T23:59:59+00:00","discovered_at":"2026-05-14T18:03:37.881742+00:00","generated_at":"2026-06-13T17:35:10.620087+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"CannaPharmaRX appoints Dean Medwid as CEO; Dominic Colvin steps down","bullets":["Dominic Colvin stepped down as CEO effective June 1, 2023; no disagreement over operations.","Dean Medwid appointed CEO effective June 1, 2023; base salary of CDN $17,325/month plus bonus.","Medwid has 30+ years experience, previously President of New Leaf Ventures, a cannabis company.","Colvin will remain with the company providing 'leadership and vision.'","No family relationships or material interests between Medwid and other officers/directors."],"urls":{"canonical":"https://secwatch.observer/filing/0001683168-23-004371","json":"https://secwatch.observer/filing/0001683168-23-004371.json","markdown":"https://secwatch.observer/filing/0001683168-23-004371.md","text":"https://secwatch.observer/filing/0001683168-23-004371.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1081938/000168316823004371/0001683168-23-004371-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1081938/000168316823004371/cannapharmarx_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-13T17:35:10.620087+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"4bfafe821e","claim":"Dean Medwid was appointed as Chief Executive Officer at CANNAPHARMARX, INC..","evidence_excerpt":"On June 1, 2023, the Company’s Board of Directors appointed Dean Medwid as Chief Executive Officer.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1081938/000168316823004371/0001683168-23-004371-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chief Executive Officer"}],"fact_type":"executive_change"},{"claim_id":"efd4f7b381","claim":"Dominic Colvin departed as Chief Executive Officer at CANNAPHARMARX, INC..","evidence_excerpt":"Dominic Colvin stepped down as the Chief Executive Officer (“CEO”) of CannPharmaRX, Inc. (the “Company”) effective June 1, 2023.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1081938/000168316823004371/0001683168-23-004371-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"stepped down"},{"label":"Role","value":"Chief Executive Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}